Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Dec 21, 2008; 14(47): 7220-7224
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7220
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7220
Four-week pegylated interferon α-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study
Akihito Tsubota, Yoshihisa Namiki, Institute of Clinical Medicine and Research, Jikei University School of Medicine, Chiba 277-8567, Japan
Akihito Tsubota, Ken-ichi Satoh, Mashu Aizawa, Seishi Takamatsu, Toshifumi Ohkusa, Kiyotaka Fujise, Department of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine, Chiba 277-8567, Japan
Hisao Tajiri, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan
Author contributions: Tsubota A, Satoh K, Takamatsu S, and Fujise K designed the study; Tsubota A, Satoh K, Aizawa M, Takamatsu S, Ohkusa T, and Fujise K performed research; Tsubota A, Satoh K and Namiki Y analyzed data; and Tsubota A, Fujise K and Tajiri H wrote the paper.
Supported by Clinical Research Funds from Department of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine
Correspondence to: Dr. Akihito Tsubota, Institute of Clinical Medicine and Research, Jikei University School of Medicine, 163-1 Kashiwa-shita, Kashiwa, Chiba 277-8567, Japan. atsubo@jikei.ac.jp
Telephone: +81-4-7164-1111 Fax: +81-4-7166-8638
Received: August 13, 2008
Revised: November 18, 2008
Accepted: November 25, 2008
Published online: December 21, 2008
Revised: November 18, 2008
Accepted: November 25, 2008
Published online: December 21, 2008
Core Tip